Website profile

Korea Biomedical Review

KBR

  • 179articles · 30d
  • 9+ hour agolatest article
  • Aug 17, 2026earliest in window
  • 78%with images
  • 327avg words
articles per day
Categories
  • Medical 142
  • Health & Wellness 120
  • Health 95
  • Economy, Business & Finance 49
  • Science & Technology 24
  • Business & Industrial 21
  • Finance & Business 15
  • News 13

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Huinno passes technology assessment for Kosdaq special listing

12+ hour, 48+ min ago   (330+ words) Huinno, a digital healthcare company specializing in AI-powered cardiac monitoring, has passed the technology assessment required for a technology-based special listing on Kosdaq, moving a step closer to an initial public offering. Intermittent arrhythmias can be difficult to detect through…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

[Interview] Angel Robotics expands in Southeast Asia ahead of US, European push

13+ hour, 59+ min ago   (1132+ words) Korea's Angel Robotics is expanding its wearable rehabilitation robot business in Southeast Asia, using the region to build regulatory and commercial experience before pursuing larger markets in the U.S. and Europe. At a press briefing on Friday, CEO Cho Nam-min said…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

COSMECCA KOREA plans $150 mil. AI-based skincare factory in Korea

4+ day, 8+ hour ago   (192+ words) Korean cosmetics contract manufacturer COSMECCA KOREA said on Thursday it will invest 200 billion won ($150 million) to build a new skincare production complex, betting on sustained global demand for Korean beauty (K-beauty) products. The company, which makes cosmetics on an original…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

ROKIT Healthcare enters Hainan Lecheng, targets 1st skin regeneration procedure within 4 months

4+ day, 9+ hour ago   (451+ words) ROKIT Healthcare has signed a distribution agreement to introduce its AI-based skin regeneration platform in China’s Hainan Boao Lecheng International Medical Tourism Pilot Zone. Following local administrative approvals and hospital adoption procedures, ROKIT Healthcare plans to conduct its first skin…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Korea’s rare-disease drug market grows nearly fivefold in decade: IQVIA

4+ day, 9+ hour ago   (459+ words) Korea’s rare-disease drug market grew nearly fivefold over the past decade to about 1.2 trillion won ($896 million) in 2025, outpacing the broader pharmaceutical market, according to an IQVIA Korea analysis. IQVIA Korea said Thursday the findings were based on sales data from…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Macrogen to offer 10x Genomics spatial biology platform in Asia first

5+ day, 8+ hour ago   (292+ words) Macrogen, a Korean genomics company, said on Wednesday it would become the first company in Asia to offer Atera, a tissue-analysis platform made by the U.S. firm 10x Genomics, adding to the services it sells to researchers working on precision medicine and…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Drug delivery divides Korea as telemedicine heads for December rollout

6+ day, 8+ hour ago   (862+ words) Supporters and opponents of expanded telemedicine and prescription drug delivery are clashing ahead of the system’s December introduction, as access concerns collide with worries over drug misuse and rising health insurance costs. As of 9:30 p.m. Sunday, it had received 29,527 signatures....

Korea Biomedical Review
koreabiomed.com > news > articleView.html

SK biopharmaceuticals puts physicians at center of global drug development

6+ day, 12+ hour ago   (792+ words) SK biopharmaceuticals is strengthening its R&D capabilities by bringing in global experts across drug discovery and clinical development, while focusing on physician-led development that incorporates patient needs and clinical practice early in the process. The company said Tuesday that…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Is Korea slipping down global pharma's drug launch priority list?

1+ week, 7+ hour ago   (1641+ words) The Korean government and pharmaceutical industry are at odds over whether Korea is losing priority in global drug launches, as multinational drugmakers reassess where to introduce innovative medicines first amid growing pressure over international price differences. The Ministry of Health…...

Korea Biomedical Review
koreabiomed.com > news > articleView.html

Dong-A ST signs deal to supply wearable patient monitor HiCardi in 6 Asia-Pacific markets

1+ week, 8+ hour ago   (319+ words) Dong-A ST said Monday it has signed a supply agreement with Schiller Asia Pacific to distribute its wearable patient monitoring platform HiCardi in six Asia-Pacific markets, expanding the Korean drugmaker’s push into digital healthcare overseas. Under the agreement, Dong-A ST…...